$LGND Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in LIGAND PHARMACEUTICALS INC. Get notifications about new insider transactions in LIGAND PHARMACEUTICALS INC for free.
Page: < prev 1 ... 7 8 9 10 11 12 13 14 15 ... 15 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 05 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.04 | 16,000 | 32,574 | 13,451,992 | 13.4 M to 13.5 M (+0.12 %) |
Dec 05 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.04 | 23,300 | 47,436 | 13,435,992 | 13.4 M to 13.4 M (+0.17 %) |
Dec 05 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.95 | 16,000 | 31,194 | 13,412,692 | 13.4 M to 13.4 M (+0.12 %) |
Dec 05 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.95 | 5,000 | 9,748 | 13,396,692 | 13.4 M to 13.4 M (+0.04 %) |
Dec 05 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.95 | 6,739 | 13,138 | 13,391,692 | 13.4 M to 13.4 M (+0.05 %) |
Dec 03 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.90 | 115,000 | 218,040 | 13,384,953 | 13.3 M to 13.4 M (+0.87 %) |
Dec 03 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.90 | 32,000 | 60,672 | 13,269,953 | 13.2 M to 13.3 M (+0.24 %) |
Dec 03 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.90 | 46,000 | 87,216 | 13,237,953 | 13.2 M to 13.2 M (+0.35 %) |
Dec 03 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.86 | 79,000 | 147,248 | 13,191,953 | 13.1 M to 13.2 M (+0.60 %) |
Dec 03 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.86 | 22,000 | 41,006 | 13,112,953 | 13.1 M to 13.1 M (+0.17 %) |
Dec 03 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.86 | 30,700 | 57,222 | 13,090,953 | 13.1 M to 13.1 M (+0.24 %) |
Dec 01 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.99 | 144,000 | 287,050 | 13,060,253 | 12.9 M to 13.1 M (+1.11 %) |
Dec 01 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.99 | 40,000 | 79,736 | 12,916,253 | 12.9 M to 12.9 M (+0.31 %) |
Dec 01 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.99 | 56,600 | 112,826 | 12,876,253 | 12.8 M to 12.9 M (+0.44 %) |
Dec 01 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.97 | 242,000 | 477,393 | 12,819,653 | 12.6 M to 12.8 M (+1.92 %) |
Dec 01 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.97 | 68,000 | 134,144 | 12,577,653 | 12.5 M to 12.6 M (+0.54 %) |
Dec 01 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.97 | 98,000 | 193,325 | 12,509,653 | 12.4 M to 12.5 M (+0.79 %) |
Dec 01 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.93 | 560,000 | 1,080,800 | 12,411,653 | 11.9 M to 12.4 M (+4.73 %) |
Dec 01 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.93 | 156,000 | 301,080 | 11,851,653 | 11.7 M to 11.9 M (+1.33 %) |
Dec 01 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.93 | 226,000 | 436,180 | 11,695,653 | 11.5 M to 11.7 M (+1.97 %) |
Nov 26 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.77 | 210,000 | 372,099 | 11,469,653 | 11.3 M to 11.5 M (+1.87 %) |
Nov 26 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.77 | 59,000 | 104,542 | 11,259,653 | 11.2 M to 11.3 M (+0.53 %) |
Nov 26 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.77 | 84,000 | 148,840 | 11,200,653 | 11.1 M to 11.2 M (+0.76 %) |
Nov 26 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.01 | 85,000 | 170,935 | 11,116,653 | 11 M to 11.1 M (+0.77 %) |
Nov 26 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.01 | 24,000 | 48,264 | 11,031,653 | 11 M to 11 M (+0.22 %) |
Nov 26 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.01 | 34,000 | 68,374 | 11,007,653 | 11 M to 11 M (+0.31 %) |
Nov 24 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.78 | 111,000 | 197,192 | 10,973,653 | 10.9 M to 11 M (+1.02 %) |
Nov 24 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.78 | 31,000 | 55,072 | 10,862,653 | 10.8 M to 10.9 M (+0.29 %) |
Nov 24 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.78 | 44,744 | 79,488 | 10,831,653 | 10.8 M to 10.8 M (+0.41 %) |
Nov 24 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.26 | 6,000 | 7,585 | 10,786,909 | 10.8 M to 10.8 M (+0.06 %) |
Nov 24 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.26 | 2,000 | 2,528 | 10,780,909 | 10.8 M to 10.8 M (+0.02 %) |
Nov 24 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.26 | 1,200 | 1,517 | 10,778,909 | 10.8 M to 10.8 M (+0.01 %) |
Nov 20 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.39 | 20,000 | 27,822 | 10,777,709 | 10.8 M to 10.8 M (+0.19 %) |
Nov 20 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.39 | 5,000 | 6,956 | 10,757,709 | 10.8 M to 10.8 M (+0.05 %) |
Nov 20 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.39 | 8,000 | 11,129 | 10,752,709 | 10.7 M to 10.8 M (+0.07 %) |
Nov 20 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.38 | 48,000 | 66,360 | 10,744,709 | 10.7 M to 10.7 M (+0.45 %) |
Nov 20 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.38 | 13,000 | 17,973 | 10,696,709 | 10.7 M to 10.7 M (+0.12 %) |
Nov 20 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.38 | 20,400 | 28,203 | 10,683,709 | 10.7 M to 10.7 M (+0.19 %) |
Nov 18 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.33 | 55,000 | 73,128 | 10,663,309 | 10.6 M to 10.7 M (+0.52 %) |
Nov 18 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.33 | 15,000 | 19,944 | 10,608,309 | 10.6 M to 10.6 M (+0.14 %) |
Nov 18 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.33 | 22,000 | 29,251 | 10,593,309 | 10.6 M to 10.6 M (+0.21 %) |
Nov 18 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.30 | 125,000 | 162,500 | 10,571,309 | 10.4 M to 10.6 M (+1.20 %) |
Nov 18 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.30 | 34,000 | 44,200 | 10,446,309 | 10.4 M to 10.4 M (+0.33 %) |
Nov 18 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.30 | 50,000 | 65,000 | 10,412,309 | 10.4 M to 10.4 M (+0.48 %) |
Nov 18 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 1,000 | 1,350 | 10,362,309 | 10.4 M to 10.4 M (+0.01 %) |
Nov 14 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.34 | 56,000 | 75,202 | 10,361,309 | 10.3 M to 10.4 M (+0.54 %) |
Nov 14 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.34 | 16,000 | 21,486 | 10,305,309 | 10.3 M to 10.3 M (+0.16 %) |
Nov 14 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.34 | 22,000 | 29,544 | 10,289,309 | 10.3 M to 10.3 M (+0.21 %) |
Nov 14 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 9,000 | 12,138 | 10,267,309 | 10.3 M to 10.3 M (+0.09 %) |
Nov 14 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 2,000 | 2,697 | 10,258,309 | 10.3 M to 10.3 M (+0.02 %) |
Nov 14 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 3,511 | 4,735 | 10,256,309 | 10.3 M to 10.3 M (+0.03 %) |
Nov 12 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.39 | 100,000 | 139,070 | 10,252,798 | 10.2 M to 10.3 M (+0.98 %) |
Nov 12 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.39 | 28,000 | 38,940 | 10,152,798 | 10.1 M to 10.2 M (+0.28 %) |
Nov 12 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.39 | 39,850 | 55,419 | 10,124,798 | 10.1 M to 10.1 M (+0.40 %) |
Nov 12 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.36 | 119,000 | 162,316 | 10,084,948 | 10 M to 10.1 M (+1.19 %) |
Nov 12 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.36 | 33,000 | 45,012 | 9,965,948 | 9.9 M to 10 M (+0.33 %) |
Nov 12 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.36 | 46,000 | 62,744 | 9,932,948 | 9.9 M to 9.9 M (+0.47 %) |
Nov 12 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.41 | 67,000 | 94,463 | 9,886,948 | 9.8 M to 9.9 M (+0.68 %) |
Nov 12 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.41 | 19,000 | 26,788 | 9,819,948 | 9.8 M to 9.8 M (+0.19 %) |
Nov 12 2008 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.41 | 27,000 | 38,067 | 9,800,948 | 9.8 M to 9.8 M (+0.28 %) |
Aug 06 2008 | LGND | LIGAND PHARMACEUTI ... | LIGAND PHARMACEUTICALS INC | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Jun 02 2008 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
Jun 02 2008 | LGND | LIGAND PHARMACEUTI ... | Perry Jeffrey R | Director | Grant | A | 0.00 | 5,000 | 0 | 33,953 | 29 K to 34 K (+17.27 %) |
Jun 02 2008 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 5,000 | 0 | 39,700 | 34.7 K to 39.7 K (+14.41 %) |
Jun 02 2008 | LGND | LIGAND PHARMACEUTI ... | GREETHAM ELIZABETH M | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
Jun 02 2008 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Grant | A | 0.00 | 5,000 | 0 | 25,378 | 20.4 K to 25.4 K (+24.54 %) |
Jun 02 2008 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
May 09 2008 | LGND | LIGAND PHARMACEUTI ... | MEGLASSON MARTIN | V-P, Discovery Rese ... | Buy | P | 3.36 | 3,000 | 10,077 | 36,500 | 33.5 K to 36.5 K (+8.96 %) |
Mar 06 2008 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Buy | P | 3.66 | 3,000 | 10,972 | 20,378 | 17.4 K to 20.4 K (+17.26 %) |
Feb 26 2008 | LGND | LIGAND PHARMACEUTI ... | Kazmi Syed | VP, Bus. Dev. & Str ... | Option Exercise | A | 3.50 | 80,000 | 280,000 | 80,000 | |
Feb 26 2008 | LGND | LIGAND PHARMACEUTI ... | Kazmi Syed | VP, Bus. Dev. & Str ... | Grant | A | 0.00 | 18,000 | 0 | 34,710 | 16.7 K to 34.7 K (+107.72 %) |
Feb 26 2008 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | A | 3.50 | 80,000 | 280,000 | 80,000 | |
Feb 26 2008 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Grant | A | 0.00 | 18,000 | 0 | 30,263 | 12.3 K to 30.3 K (+146.78 %) |
Feb 26 2008 | LGND | LIGAND PHARMACEUTI ... | Dziewanowska Zofia E | VP, Clinical Resear ... | Option Exercise | A | 3.50 | 80,000 | 280,000 | 80,000 | |
Feb 26 2008 | LGND | LIGAND PHARMACEUTI ... | Dziewanowska Zofia E | VP, Clinical Resear ... | Grant | A | 0.00 | 18,000 | 0 | 32,977 | 15 K to 33 K (+120.18 %) |
Feb 26 2008 | LGND | LIGAND PHARMACEUTI ... | MEGLASSON MARTIN | V-P, Discovery Rese ... | Option Exercise | A | 3.50 | 85,000 | 297,500 | 85,000 | |
Feb 26 2008 | LGND | LIGAND PHARMACEUTI ... | MEGLASSON MARTIN | V-P, Discovery Rese ... | Grant | A | 0.00 | 20,000 | 0 | 33,500 | 13.5 K to 33.5 K (+148.15 %) |
Feb 26 2008 | LGND | LIGAND PHARMACEUTI ... | Sharp John P | VP Finance and CFO | Option Exercise | A | 3.50 | 80,000 | 280,000 | 80,000 | |
Feb 26 2008 | LGND | LIGAND PHARMACEUTI ... | Sharp John P | VP Finance and CFO | Grant | A | 0.00 | 18,000 | 0 | 33,000 | 15 K to 33 K (+120.00 %) |
Feb 26 2008 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | President & CEO | Option Exercise | A | 3.50 | 260,000 | 910,000 | 260,000 | |
Feb 26 2008 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | President & CEO | Grant | A | 0.00 | 75,000 | 0 | 229,000 | 154 K to 229 K (+48.70 %) |
Nov 23 2007 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Buy | P | 4.28 | 2,000 | 8,560 | 17,378 | 15.4 K to 17.4 K (+13.01 %) |
Aug 30 2007 | LGND | LIGAND PHARMACEUTI ... | MEGLASSON MARTIN | V-P, Discovery Rese ... | Buy | P | 6.20 | 612 | 3,794 | 13,500 | 12.9 K to 13.5 K (+4.75 %) |
Aug 30 2007 | LGND | LIGAND PHARMACEUTI ... | MEGLASSON MARTIN | V-P, Discovery Rese ... | Buy | P | 6.19 | 1,388 | 8,592 | 12,888 | 11.5 K to 12.9 K (+12.07 %) |
Aug 29 2007 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Buy | P | 6.14 | 1,000 | 6,140 | 15,378 | 14.4 K to 15.4 K (+6.96 %) |
Aug 14 2007 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Buy | P | 6.02 | 500 | 3,010 | 14,378 | 13.9 K to 14.4 K (+3.60 %) |
Aug 14 2007 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Buy | P | 6.01 | 1,500 | 9,015 | 13,878 | 12.4 K to 13.9 K (+12.12 %) |
Aug 13 2007 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | President & CEO | Buy | P | 5.86 | 2,000 | 11,720 | 154,000 | 152 K to 154 K (+1.32 %) |
Jun 22 2007 | LGND | LIGAND PHARMACEUTI ... | Sharp John P | VP Finance and CFO | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
Jun 22 2007 | LGND | LIGAND PHARMACEUTI ... | MEGLASSON MARTIN | V-P, Discovery Rese ... | Option Exercise | A | 7.15 | 52,000 | 371,800 | 52,000 | |
Jun 22 2007 | LGND | LIGAND PHARMACEUTI ... | MEGLASSON MARTIN | V-P, Discovery Rese ... | Grant | A | 0.00 | 11,000 | 0 | 11,500 | 500 to 11.5 K (+2,200.00 %) |
Jun 22 2007 | LGND | LIGAND PHARMACEUTI ... | Dziewanowska Zofia E | VP, Clinical Resear ... | Option Exercise | A | 7.15 | 30,000 | 214,500 | 30,000 | |
Jun 22 2007 | LGND | LIGAND PHARMACEUTI ... | Dziewanowska Zofia E | VP, Clinical Resear ... | Grant | A | 0.00 | 7,000 | 0 | 12,882 | 5.9 K to 12.9 K (+119.01 %) |
Jun 22 2007 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | A | 7.15 | 32,000 | 228,800 | 32,000 | |
Jun 22 2007 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Grant | A | 0.00 | 11,000 | 0 | 12,263 | 1.3 K to 12.3 K (+870.94 %) |
Jun 19 2007 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Sell | S | 6.84 | 52,700 | 360,205 | 528,618 | 581.3 K to 528.6 K (-9.07 %) |
Jun 19 2007 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 6.84 | 33,800 | 231,023 | 581,318 | 547.5 K to 581.3 K (+6.17 %) |
Jun 19 2007 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Sell | S | 6.84 | 347,400 | 2,374,479 | 3,581,931 | 3.9 M to 3.6 M (-8.84 %) |
Jun 19 2007 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 6.84 | 3,400 | 23,239 | 21,800 | 18.4 K to 21.8 K (+18.48 %) |
Jun 19 2007 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 6.84 | 323,000 | 2,207,705 | 1,649,841 | 1.3 M to 1.6 M (+24.34 %) |
Jun 19 2007 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 6.84 | 39,900 | 272,717 | 2,459,283 | 2.4 M to 2.5 M (+1.65 %) |
Jun 18 2007 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | President & CEO | Buy | P | 6.70 | 2,000 | 13,400 | 152,000 | 150 K to 152 K (+1.33 %) |
Jun 15 2007 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Grant | A | 6.50 | 50,000 | 325,000 | 82,400 | 32.4 K to 82.4 K (+154.32 %) |
Jun 04 2007 | LGND | LIGAND PHARMACEUTI ... | Perry Jeffrey R | Director | Option Exercise | A | 6.61 | 10,000 | 66,100 | 10,000 | |
Jun 04 2007 | LGND | LIGAND PHARMACEUTI ... | GREETHAM ELIZABETH M | Director | Option Exercise | A | 6.61 | 10,000 | 66,100 | 10,000 | |
Jun 04 2007 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 6.61 | 10,000 | 66,100 | 10,000 | |
Jun 04 2007 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 6.61 | 10,000 | 66,100 | 10,000 | |
Jun 04 2007 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Option Exercise | A | 6.61 | 10,000 | 66,100 | 10,000 | |
Jun 04 2007 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | A | 6.61 | 10,000 | 66,100 | 10,000 | |
Jun 04 2007 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 6.61 | 10,000 | 66,100 | 10,000 | |
Jun 01 2007 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 6.48 | 3,350 | 21,708 | 12,150 | 8.8 K to 12.2 K (+38.07 %) |
Jun 01 2007 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 6.48 | 5,000 | 32,400 | 29,700 | 24.7 K to 29.7 K (+20.24 %) |
May 02 2007 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | Asso. Gen. Counsel, ... | Option Exercise | A | 6.81 | 20,000 | 136,200 | 20,000 | |
May 02 2007 | LGND | LIGAND PHARMACEUTI ... | Sharp John P | VP Finance and CFO | Option Exercise | A | 6.81 | 50,000 | 340,500 | 50,000 | |
Apr 04 2007 | LGND | LIGAND PHARMACEUTI ... | BLISSENBACH HENRY F | Director | Option Exercise | M | 5.68 | 857 | 4,870 | 0 | |
Apr 04 2007 | LGND | LIGAND PHARMACEUTI ... | BLISSENBACH HENRY F | Director | Option Exercise | M | 4.98 | 1,507 | 7,499 | 0 | |
Apr 04 2007 | LGND | LIGAND PHARMACEUTI ... | BLISSENBACH HENRY F | Director | Option Exercise | M | 4.62 | 756 | 3,496 | 0 | |
Apr 04 2007 | LGND | LIGAND PHARMACEUTI ... | BLISSENBACH HENRY F | Director | Option Exercise | M | 4.58 | 763 | 3,497 | 0 | |
Apr 04 2007 | LGND | LIGAND PHARMACEUTI ... | BLISSENBACH HENRY F | Director | Option Exercise | M | 3.73 | 2,009 | 7,500 | 0 | |
Apr 04 2007 | LGND | LIGAND PHARMACEUTI ... | BLISSENBACH HENRY F | Director | Option Exercise | M | 1.82 | 4,113 | 7,499 | 0 | |
Apr 04 2007 | LGND | LIGAND PHARMACEUTI ... | BLISSENBACH HENRY F | Director | Buy | M | 3.73 | 2,009 | 7,500 | 15,005 | 13 K to 15 K (+15.46 %) |
Apr 04 2007 | LGND | LIGAND PHARMACEUTI ... | BLISSENBACH HENRY F | Director | Buy | M | 4.98 | 1,507 | 7,499 | 12,996 | 11.5 K to 13 K (+13.12 %) |
Apr 04 2007 | LGND | LIGAND PHARMACEUTI ... | BLISSENBACH HENRY F | Director | Buy | M | 1.82 | 4,113 | 7,499 | 11,489 | 7.4 K to 11.5 K (+55.76 %) |
Apr 04 2007 | LGND | LIGAND PHARMACEUTI ... | BLISSENBACH HENRY F | Director | Buy | M | 5.68 | 857 | 4,870 | 7,376 | 6.5 K to 7.4 K (+13.15 %) |
Apr 04 2007 | LGND | LIGAND PHARMACEUTI ... | BLISSENBACH HENRY F | Director | Buy | M | 4.58 | 763 | 3,497 | 6,519 | 5.8 K to 6.5 K (+13.26 %) |
Apr 04 2007 | LGND | LIGAND PHARMACEUTI ... | BLISSENBACH HENRY F | Director | Buy | M | 4.62 | 756 | 3,496 | 5,756 | 5 K to 5.8 K (+15.12 %) |
Mar 05 2007 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | A | 11.39 | 20,000 | 227,800 | 20,000 | |
Mar 08 2007 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Option Exercise | A | 11.39 | 20,000 | 227,800 | 20,000 | |
Mar 28 2007 | LGND | LIGAND PHARMACEUTI ... | Loeb Daniel S | Sell | S | 10.54 | 5,720,000 | 60,288,800 | 2,027,378 | 7.7 M to 2 M (-73.83 %) | |
Mar 05 2007 | LGND | LIGAND PHARMACEUTI ... | GREETHAM ELIZABETH M | Director | Option Exercise | A | 11.39 | 20,000 | 227,800 | 20,000 | |
Jan 05 2007 | LGND | LIGAND PHARMACEUTI ... | Perry Jeffrey R | Director | Option Exercise | A | 3.64 | 3,781 | 13,749 | 3,781 | |
Feb 05 2007 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | CEO & President | Grant | A | 12.68 | 150,000 | 1,902,000 | 150,000 | 0 to 150 K |
Jan 05 2007 | LGND | LIGAND PHARMACEUTI ... | Roberts Brigette | Director | Option Exercise | A | 3.64 | 3,781 | 13,749 | 3,781 | |
Jan 05 2007 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 3.64 | 3,781 | 13,749 | 3,781 | |
Jan 05 2007 | LGND | LIGAND PHARMACEUTI ... | CROSS ALEXANDER D | Director | Option Exercise | A | 3.64 | 3,781 | 13,749 | 3,781 | |
Jan 05 2007 | LGND | LIGAND PHARMACEUTI ... | JOHNSON IRVING S | Director | Option Exercise | A | 3.64 | 3,781 | 13,749 | 3,781 | |
Jan 05 2007 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 3.64 | 3,781 | 13,749 | 3,781 | |
Dec 19 2006 | LGND | LIGAND PHARMACEUTI ... | GROVES ERIC S | V-P, Project Manage ... | Option Exercise | M | 7.63 | 2,511 | 19,146 | 0 | |
Dec 19 2006 | LGND | LIGAND PHARMACEUTI ... | GROVES ERIC S | V-P, Project Manage ... | Option Exercise | M | 7.63 | 27,476 | 209,505 | 2,511 | |
Dec 19 2006 | LGND | LIGAND PHARMACEUTI ... | GROVES ERIC S | V-P, Project Manage ... | Option Exercise | M | 7.63 | 20,013 | 152,599 | 29,987 | |
Dec 19 2006 | LGND | LIGAND PHARMACEUTI ... | GROVES ERIC S | V-P, Project Manage ... | Sell | S | 11.22 | 2,511 | 28,173 | 5,127 | 7.6 K to 5.1 K (-32.88 %) |
Dec 19 2006 | LGND | LIGAND PHARMACEUTI ... | GROVES ERIC S | V-P, Project Manage ... | Buy | M | 7.63 | 2,511 | 19,146 | 7,638 | 5.1 K to 7.6 K (+48.98 %) |
Dec 19 2006 | LGND | LIGAND PHARMACEUTI ... | GROVES ERIC S | V-P, Project Manage ... | Sell | S | 11.22 | 27,476 | 308,281 | 5,127 | 32.6 K to 5.1 K (-84.27 %) |
Dec 19 2006 | LGND | LIGAND PHARMACEUTI ... | GROVES ERIC S | V-P, Project Manage ... | Buy | M | 7.63 | 27,476 | 209,505 | 32,603 | 5.1 K to 32.6 K (+535.91 %) |
Dec 19 2006 | LGND | LIGAND PHARMACEUTI ... | GROVES ERIC S | V-P, Project Manage ... | Sell | S | 11.25 | 20,013 | 225,146 | 5,127 | 25.1 K to 5.1 K (-79.61 %) |
Dec 19 2006 | LGND | LIGAND PHARMACEUTI ... | GROVES ERIC S | V-P, Project Manage ... | Buy | M | 7.63 | 20,013 | 152,599 | 25,140 | 5.1 K to 25.1 K (+390.35 %) |
Dec 19 2006 | LGND | LIGAND PHARMACEUTI ... | MEGLASSON MARTIN | V-P, Discovery Rese ... | Option Exercise | M | 7.25 | 5,313 | 38,519 | 9,687 | |
Dec 19 2006 | LGND | LIGAND PHARMACEUTI ... | MEGLASSON MARTIN | V-P, Discovery Rese ... | Sell | S | 11.23 | 5,313 | 59,656 | 500 | 5.8 K to 500 (-91.40 %) |
Dec 19 2006 | LGND | LIGAND PHARMACEUTI ... | MEGLASSON MARTIN | V-P, Discovery Rese ... | Buy | M | 7.25 | 5,313 | 38,519 | 5,813 | 500 to 5.8 K (+1,062.60 %) |
Dec 19 2006 | LGND | LIGAND PHARMACEUTI ... | PETTTIT WILLIAM A | Sr. V-P, HR and Adm ... | Option Exercise | M | 10.68 | 138 | 1,474 | 0 |